Latest / The Bill Handel Show / Dogs at Work | ‘Medical News’ with Dr. Jim Keany

Transcript

Dogs at Work | ‘Medical News’ with Dr. Jim Keany · The Bill Handel Show

• 0:00
  Speaker 1: You're listening to KFI AM 640, the Bill Handel Show
• 0:04
  Speaker 1: on demand on the iHeartRadio app.
• 0:07
  Speaker 2: There are horses in heaven.
• 0:11
  Speaker 1: Yeah, I bet the gods are cowboys.
• 0:16
  Speaker 2: KFI AM 640, Bill Handel on a Wednesday morning, August 26th.
• 0:19
  Speaker 2: Some of the stories we are looking at. And that
• 0:23
  Speaker 2: is the sister of Senator Lindsey Graham, Darlene Graham Smith.
• 0:30
  Speaker 2: has won the nomination to be the Republican nominee for
• 0:35
  Speaker 2: the Senate in South Carolina, and she has zero experience,
• 0:39
  Speaker 2: has no idea in terms of foreign affairs. She said
• 0:43
  Speaker 2: that outright, and she won because Trump put her up,
• 0:48
  Speaker 2: suggested that she goes, talked her into it, and it
• 0:51
  Speaker 2: just goes to show that the president still has unbelievable
• 0:54
  Speaker 2: experience influence and power in, uh, the Republican party. We'll
• 0:58
  Speaker 2: see what happens during the midterms, the election. Okay. Now, uh,
• 1:02
  Speaker 2: story about wild horses. There's a song there. Isn't it
• 1:05
  Speaker 2: wild horses or is it mild horses, horses that are
• 1:09
  Speaker 2: very gentle? It's a song about something. I don't even know. Uh,
• 1:12
  Speaker 2: but it's about horses. I know that, uh, that's completely
• 1:17
  Speaker 2: incidental to this story. So, uh, there are wild Mustangs, uh, in, uh,
• 1:23
  Speaker 2: in the West, uh, And they actually run free through
• 1:26
  Speaker 2: the desert mountains. And there's a ton of them. I
• 1:30
  Speaker 2: had no idea there were this many. On federal land,
• 1:34
  Speaker 2: there are about 58,000 horses that are running around. Pretty impressive.
• 1:42
  Speaker 2: So they used to run free. Then the federal government
• 1:45
  Speaker 2: started rounding them up with helicopters. It's done that with
• 1:48
  Speaker 2: tens of thousands of other horses. And they attempt, the
• 1:51
  Speaker 2: government attempts to control the population on public lands because
• 1:55
  Speaker 2: they have to. I mean, they have to call the herds.
• 1:58
  Speaker 2: And what happened was the herds were held for years
• 2:01
  Speaker 2: in a feedlot in Idaho. And the government tried to
• 2:05
  Speaker 2: find them what the government calls loving homes.
• 2:08
  Speaker 3: And they do.
• 2:09
  Speaker 2: So this March, that changed a little bit. The horses
• 2:12
  Speaker 2: were packed into metal trailers. They were trucked 1,800 miles
• 2:15
  Speaker 2: east to a livestock trader, a pen farmer. or pens.
• 2:22
  Speaker 2: And the trader bought every one of these horses for
• 2:26
  Speaker 2: $ 25 a piece. And a day later after the purchase,
• 2:30
  Speaker 2: cattle trucks pulled up at midnight, loaded the Mustangs on
• 2:34
  Speaker 2: and drove on to the night. And from there, these
• 2:37
  Speaker 2: horses disappeared. No one knows where they went. They were
• 2:39
  Speaker 2: supposed to go to public auction because that's what the
• 2:42
  Speaker 2: law says. If they can't, have them adopted, they go
• 2:47
  Speaker 2: to public auction where they can be bought. But the
• 2:50
  Speaker 2: law still says you can't destroy them. You can't kill them.
• 2:54
  Speaker 2: You can't hunt them down. So they never went to
• 2:58
  Speaker 2: public auction. Wild horse advocates saying, I'll tell you where
• 3:01
  Speaker 2: they went. They went to the slaughterhouse. And it wasn't
• 3:05
  Speaker 2: the first time. It won't be the last time the
• 3:07
  Speaker 2: government has shipped this trader a truckload after truckload of
• 3:14
  Speaker 2: these horses that have not been adopted. It is a
• 3:18
  Speaker 2: big scandal going on. New York Times looked at some
• 3:22
  Speaker 2: government records and found that all over the country, the
• 3:27
  Speaker 2: Bureau of Land Management, the BLM, the agency in charge
• 3:31
  Speaker 2: of protecting wild horses, is selling thousands of these horses
• 3:35
  Speaker 2: to buyers, ostensibly to protect them. You know, either adopt
• 3:42
  Speaker 2: them or people buy them. And what they can't do
• 3:45
  Speaker 2: is slaughter them. It's illegal, but there's a loophole that
• 3:50
  Speaker 2: enables people to get those Mustangs on the cheap. And
• 3:53
  Speaker 2: then we sell them to be exported alive and then
• 3:58
  Speaker 2: off to the slaughterhouse and become meat and sell it abroad. France,
• 4:03
  Speaker 2: they eat horses. And the livestock inspection also showed that
• 4:10
  Speaker 2: these horses sold by the government ended up at slaughterhouses
• 4:14
  Speaker 2: in Canada.
• 4:16
  Speaker 4: Now, the U.S.
• 4:17
  Speaker 2: Government, the sales of wild horses were rare. But after
• 4:20
  Speaker 2: the president took office, they started to creep up and up.
• 4:23
  Speaker 2: Matter of fact, they more than doubled in 2025 to
• 4:27
  Speaker 2: more than 3,700 horses. And in that time, the Bureau
• 4:32
  Speaker 2: sent about 500 horses to this one buyer. And they
• 4:35
  Speaker 2: came in from all over the West. Now, the buyer
• 4:38
  Speaker 2: said he was able to resell the horses quickly, but
• 4:42
  Speaker 2: he wouldn't say where the horses went. And he said,
• 4:45
  Speaker 2: I didn't sell any of them to any slaughterhouses. Now,
• 4:48
  Speaker 2: here's some stats. The government can spend about $ 3, 000 to
• 4:52
  Speaker 2: capture a Mustang, bring it to market, but can sell
• 4:55
  Speaker 2: it and does sell it for as little as $ 25.
• 4:58
  Speaker 2: A slaughterhouse will pay about $ 750 per horse. That's how
• 5:06
  Speaker 2: much they're worth. So the government is selling horses at
• 5:12
  Speaker 2: a huge loss. animal welfare organizations say the agency in
• 5:17
  Speaker 2: charge of protecting the horses, the BLM, is instead subsidizing
• 5:23
  Speaker 2: their destruction. That's the allegation. The BLM is saying to
• 5:28
  Speaker 2: the public that slaughter is off the table. We do
• 5:30
  Speaker 2: not slaughter horses and we don't send them to the slaughterhouses.
• 5:35
  Speaker 2: But in fact, they're doing it using a third party,
• 5:40
  Speaker 2: according to Claire Staples, who runs the Wild Horse Sanctuary.
• 5:45
  Speaker 2: And how do they do this? Well, considering, oh, I
• 5:48
  Speaker 2: was wrong up the number. There are 73,000 wild horses
• 5:51
  Speaker 2: now in federal lands, and they're protected from hunting or capture.
• 5:56
  Speaker 2: And every year, the Bureau rounds up about 9,500 horses,
• 6:00
  Speaker 2: offers them for adoption. About half of them are adopted.
• 6:04
  Speaker 2: The rest go into feedlots and pastures that the Bureau
• 6:07
  Speaker 2: calls the holding system. Now holding 58,000 horses at a
• 6:10
  Speaker 2: cost of about $ 100 million. And that eats up most
• 6:15
  Speaker 2: of the Bureau's wild horse budget. And for a bunch
• 6:19
  Speaker 2: of years, the Bureau has floated ideas how to reduce
• 6:23
  Speaker 2: the herds, sharpshooters killing them, selling horses directly to slaughterhouses,
• 6:29
  Speaker 2: but they have to change the law. Congress, aware that
• 6:33
  Speaker 2: these horses have to be protected, the public goes nuts,
• 6:37
  Speaker 2: has barred the Bureau from spending any money to kill
• 6:40
  Speaker 2: healthy wild horses. So you've heard of Project 2025. The
• 6:44
  Speaker 2: Heritage Foundation issued this as a sort of a blueprint
• 6:47
  Speaker 2: for the second Trump administration. They've argued that the Bureau
• 6:51
  Speaker 2: needs to be able to cut costs by killing horses.
• 6:55
  Speaker 2: And Congress has to enact laws killing horses humanely. Are
• 7:00
  Speaker 2: there alternatives? Yeah, there are. For example, there are inexpensive
• 7:05
  Speaker 2: fertility control drugs delivered by a dart gun. So what
• 7:09
  Speaker 2: happens is the horses can't reproduce. and they end up
• 7:12
  Speaker 2: dying and the population decreases on its own. So the
• 7:17
  Speaker 2: Bureau can't kill wild horses now, but there are bureaucratic maneuvers. First,
• 7:23
  Speaker 2: BLM has to show a wild horse can't be adopted.
• 7:26
  Speaker 2: And they post these horses on its online adoption site.
• 7:31
  Speaker 2: After a horse has three one-week listings, no takers, then
• 7:35
  Speaker 2: the government designates it as unadoptable. Then it can be
• 7:38
  Speaker 2: put up for sale. And once a horse is put
• 7:42
  Speaker 2: up for sale, all the protections of the wild horses stop.
• 7:47
  Speaker 2: It's over. Now the horses go wherever they want. And
• 7:50
  Speaker 2: the reality is that a whole lot of them are
• 7:53
  Speaker 2: being killed.
• 7:54
  Speaker 3: It's a shame.
• 7:55
  Speaker 2: It really is. Just thought I'd share that with you.
• 7:58
  Speaker 2: It's a story. All right, now let's get fun. Okay,
• 8:01
  Speaker 2: now I want to spend a minute or two talking
• 8:04
  Speaker 2: about policy and offices. And that is letting dogs in
• 8:10
  Speaker 2: to offices.
• 8:12
  Speaker 3: Quick question.
• 8:12
  Speaker 2: Do we, we don't have an office policy. Do we
• 8:15
  Speaker 2: at KFI? I think we do where dogs are not allowed.
• 8:17
  Speaker 3: Dogs are not allowed.
• 8:19
  Speaker 1: Yeah.
• 8:19
  Speaker 2: But I mean, does anybody pay attention since.
• 8:22
  Speaker 3: We had to.
• 8:23
  Speaker 2: You did? This was Neil.
• 8:25
  Speaker 3: Someone brought a massive dog in. Massive.
• 8:30
  Speaker 2: And the dog decided to crap in the hallway.
• 8:33
  Speaker 1: Yeah.
• 8:33
  Speaker 4: Okay.
• 8:33
  Speaker 2: Okay. Well, it used to be, I have seen dogs
• 8:37
  Speaker 2: in the office at the studio, but they were small dogs.
• 8:41
  Speaker 2: Matter of fact, here comes one of mine right now.
• 8:43
  Speaker 2: Matter of fact, they're both here because I have a
• 8:47
  Speaker 2: pro-dog policy where I'm broadcasting from my house and I
• 8:51
  Speaker 2: happen to like dogs. And most people do like dogs.
• 8:54
  Speaker 2: But what do you do when you have an office
• 8:56
  Speaker 2: that's pro-dog and it's one of the perks of And
• 9:00
  Speaker 2: I'm assuming that when you go into especially tech, high-tech places,
• 9:06
  Speaker 2: dogs are bouncing around all over the place because it's
• 9:08
  Speaker 2: just dog-friendly atmosphere. What do you do when you have
• 9:14
  Speaker 2: a person who is either allergic to dogs or doesn't
• 9:17
  Speaker 2: like dogs and that person pipes up? Ooh, that's a
• 9:25
  Speaker 2: bad one. That is a bad one. You can't Dislike dogs.
• 9:31
  Speaker 2: You can't. Well, what about that dogs are distracting? Is
• 9:36
  Speaker 2: that a problem? You can't dislike dogs. This is a
• 9:39
  Speaker 2: story that came out of Slate. And there are some
• 9:42
  Speaker 2: quotes here, which I absolutely love. Here's one. This was
• 9:47
  Speaker 2: during an interview about this story. Our office building used
• 9:51
  Speaker 2: to be dog friendly. Then two dogs consummated their relationship
• 9:56
  Speaker 2: in the hallway. All right, that's entertainment. And then the
• 10:02
  Speaker 2: one attorney's dog bit one of his clients. Someone else's
• 10:04
  Speaker 2: dog got off leash during a walk, almost hit by
• 10:07
  Speaker 2: a car. And then there's some stories about the dogs
• 10:09
  Speaker 2: going out in the hallways and deciding that that is
• 10:13
  Speaker 2: where they're going to relieve themselves. That becomes problematic. Now,
• 10:19
  Speaker 2: if I like dogs, that's just too bad. And so
• 10:22
  Speaker 2: here is a question. I'm going to go around and
• 10:25
  Speaker 2: around and around. Neil, dogs in the office.
• 10:28
  Speaker 3: What do you think?
• 10:29
  Speaker 4: No.
• 10:30
  Speaker 3: Okay.
• 10:31
  Speaker 2: Amy, dogs in the office.
• 10:32
  Speaker 3: I don't think so. Okay.
• 10:34
  Speaker 2: Kono, dogs in the office. Oh, yeah.
• 10:36
  Speaker 3: Bring them on.
• 10:37
  Speaker 1: Good.
• 10:37
  Speaker 2: That's one. Two to one. Ann, dogs in the office. 100%.
• 10:43
  Speaker 4: Yes.
• 10:43
  Speaker 2: Okay.
• 10:44
  Speaker 3: Dog lover.
• 10:44
  Speaker 2: So that's two, two, two. All right. Will, dogs in
• 10:49
  Speaker 2: the office.
• 10:53
  Speaker 3: His headphones aren't on.
• 10:55
  Speaker 2: That's right. He is staring at the screen. He's looking
• 10:57
  Speaker 2: at traffic. He is. He's looking at dogs in traffic.
• 11:01
  Speaker 2: That's correct. He's looking at dogs in traffic. And I
• 11:05
  Speaker 2: am ambivalent about it. I'm fine with dogs that are dead,
• 11:11
  Speaker 2: for example, because they don't make too big a deal
• 11:14
  Speaker 2: out of it. You know, I have five dead dogs
• 11:16
  Speaker 2: at home. You know that. This is Lindsay. Five dead
• 11:21
  Speaker 2: dogs in boxes. Boy, is that pleasant for me. I
• 11:23
  Speaker 2: think I have six.
• 11:25
  Speaker 3: Oh, God.
• 11:26
  Speaker 2: I don't understand it.
• 11:27
  Speaker 4: I don't.
• 11:27
  Speaker 2: I have a cat.
• 11:29
  Speaker 3: Oh, and the dog's back at my mom's house.
• 11:32
  Speaker 2: My rabbits are buried in the backyard.
• 11:34
  Speaker 3: I don't get it. I don't get it.
• 11:36
  Speaker 2: I mean, even dead dogs in boxes.
• 11:43
  Speaker 3: Can people start bringing lizards and... snakes and stuff too.
• 11:48
  Speaker 2: I think so i think if you have a pet
• 11:50
  Speaker 2: tarantula yeah i think you probably could i had a pet.
• 11:54
  Speaker 3: Rat for a long time can i agree all right will.
• 11:57
  Speaker 2: Uh oh he's still uh okay never mind all right
• 12:03
  Speaker 2: story i just want to share with you about dogs
• 12:05
  Speaker 2: in the office and uh in my case uh yes
• 12:09
  Speaker 2: unless i don't like them and so we have to
• 12:12
  Speaker 2: do i will do a dog interview and if the
• 12:15
  Speaker 2: dog i like the dog then yes All right. That's it.
• 12:20
  Speaker 2: We're done with that.
• 12:21
  Speaker 3: Okay.
• 12:22
  Speaker 4: Dr.
• 12:23
  Speaker 2: Jim Keeney, who is the chief medical officer for Dignity St.
• 12:27
  Speaker 2: Mary Medical Center in Long Beach, and our medical go-to guy, Jim,
• 12:32
  Speaker 2: good morning to you.
• 12:33
  Speaker 4: Good morning, Bill.
• 12:35
  Speaker 1: Okay.
• 12:36
  Speaker 2: A couple things I want to talk about. There is
• 12:39
  Speaker 2: one question that is actually Ann brought to the table
• 12:44
  Speaker 2: this morning, and she asked me earlier, I didn't know
• 12:46
  Speaker 2: why she asked me, And she said, Bill, can you
• 12:48
  Speaker 2: stand on one leg for 30 seconds? And I said,
• 12:52
  Speaker 2: I can't stand on one leg if I'm with a walker,
• 12:55
  Speaker 2: much less standing on one leg for 30 seconds. I
• 12:58
  Speaker 2: have absolutely no balance. You know that. We've talked about that.
• 13:01
  Speaker 2: And here's the scary part. Is balance a key to
• 13:05
  Speaker 2: a long life? And here's another one. I'm going to
• 13:08
  Speaker 2: be dead next week because I have no balance. So
• 13:11
  Speaker 2: what do I do until then, until I die next Wednesday?
• 13:14
  Speaker 2: What's going on with this story?
• 13:16
  Speaker 3: Right.
• 13:17
  Speaker 4: So, I mean, I think the story implies if you
• 13:20
  Speaker 4: can balance on one leg, it can tell you how
• 13:23
  Speaker 4: long you're going to live. And that's really not the headline.
• 13:26
  Speaker 4: The headline is more that balance isn't this magic longevity test,
• 13:31
  Speaker 4: but it's a really simple window into how well the brain,
• 13:35
  Speaker 4: the sensory system, nerves, muscles, joints, everything is all working together.
• 13:40
  Speaker 4: So it's almost like the like the check engine light
• 13:42
  Speaker 4: on your on your dashboard. It's like, OK, you know,
• 13:46
  Speaker 4: everything's doing fine. If you can, if that light's not
• 13:49
  Speaker 4: on and you have good balance, if you don't have
• 13:52
  Speaker 4: good balance, it could be part of normal aging. It
• 13:54
  Speaker 4: could be a sign that something else is going on.
• 13:57
  Speaker 4: So it's really a very nonspecific test.
• 14:00
  Speaker 2: Yeah, still doesn't help me. So, OK, let me get
• 14:02
  Speaker 2: personal because, of course, the show is about me and
• 14:04
  Speaker 2: it's all I care about. And that is not only
• 14:08
  Speaker 2: do I have no balance, I've never particularly had balance.
• 14:10
  Speaker 2: It is getting worse. I now, when I take a walk,
• 14:14
  Speaker 2: which I do every morning, I actually stagger sometimes where
• 14:19
  Speaker 2: literally is some, if the cops showed up, they would
• 14:21
  Speaker 2: pull me aside and go, Hey, what's going on? You
• 14:24
  Speaker 2: look like you're not all there. So what does that
• 14:29
  Speaker 2: mean for me? Cause I have, it's gotten worse for
• 14:32
  Speaker 2: me in this, in the balance department. Should I worry?
• 14:36
  Speaker 4: Yeah, I mean, it's something that indicates something in that
• 14:40
  Speaker 4: whole link that I just mentioned is going on. So
• 14:43
  Speaker 4: that's a lot of different systems in your body that
• 14:45
  Speaker 4: contribute to balance. Visual, you know, your inner ear, the musculature.
• 14:52
  Speaker 4: So are you getting more weak? Are you losing muscle
• 14:55
  Speaker 4: mass so that you can't keep yourself balanced?
• 14:58
  Speaker 2: Yeah.
• 14:58
  Speaker 4: You know, so it could be any of those things.
• 15:00
  Speaker 4: And the problem is that it is part of normal aging. And,
• 15:04
  Speaker 4: you know, you've already had longevity is the interesting part.
• 15:09
  Speaker 2: Thank you.
• 15:09
  Speaker 4: You know, you just turned 75.
• 15:12
  Speaker 3: Thank you.
• 15:13
  Speaker 2: I've already laughed at you for living. Yeah, I've already
• 15:17
  Speaker 2: had longevity. So, okay.
• 15:19
  Speaker 4: It's interesting, like, right when a 90-year-old wants to know
• 15:22
  Speaker 4: the results of their longevity test, because it's like, okay,
• 15:25
  Speaker 4: life was your longevity test and you passed, right?
• 15:28
  Speaker 2: Okay, so the fact is, okay, that I'm losing my balance,
• 15:32
  Speaker 2: hopefully is not the huge issue that I'm, my hearing
• 15:36
  Speaker 2: is in trouble, my eyesight isn't as good, and my
• 15:39
  Speaker 2: scrotum is about to fall off. Put all of that together,
• 15:42
  Speaker 2: and we're looking at me.
• 15:44
  Speaker 3: I'm in trouble. Thank you, Jim.
• 15:47
  Speaker 4: Well, let's expand this, though, for the listeners, because this
• 15:49
  Speaker 4: is a fact of life is that as we age,
• 15:52
  Speaker 4: we lose the ability to balance. And so the bottom
• 15:54
  Speaker 4: line is, what can you do so that you don't
• 15:56
  Speaker 4: fall over, break a hip or hit your head even
• 15:59
  Speaker 4: worse and bleed into your brain? I can't tell you.
• 16:01
  Speaker 4: We see so much of that because people are living longer.
• 16:04
  Speaker 4: and they don't have as much medical illnesses late in
• 16:08
  Speaker 4: life as we used to see. And so they're dying
• 16:11
  Speaker 4: from hitting their head and bleeding into their brain or
• 16:13
  Speaker 4: breaking their hip. And then after you break your hip,
• 16:16
  Speaker 4: it's hard to live much longer. If you're over 70
• 16:19
  Speaker 4: and you break your hip, we're talking about a year's
• 16:21
  Speaker 4: life expectancy because of all the fallout of losing mobility.
• 16:26
  Speaker 4: So what can you do? You gotta make sure that
• 16:29
  Speaker 4: you're using a cane if that would help. You're using
• 16:32
  Speaker 4: a walker if you need one at that level. You know,
• 16:34
  Speaker 4: you you remove area rugs from your house. You're not
• 16:37
  Speaker 4: tripping over the edge of a rug. Yeah, you you
• 16:40
  Speaker 4: trip proof your home essentially. And you put your hand
• 16:44
  Speaker 4: on a railing every time you walk up and downstairs.
• 16:46
  Speaker 4: You know, there's you can go to a physical therapist
• 16:48
  Speaker 4: and they will walk you through how to reduce your
• 16:51
  Speaker 4: risk of falling. And it's not a joke. It's critical
• 16:54
  Speaker 4: that you don't fall at this age.
• 16:56
  Speaker 2: Yeah, we talked about that. And that is scary. That
• 16:59
  Speaker 2: is scary for me. I mean, all I mean, legitimately. And,
• 17:03
  Speaker 2: you know, one of the things I do do is
• 17:04
  Speaker 2: I make sure that when I go up and down
• 17:06
  Speaker 2: the stairs, I do hold on because that that's the
• 17:09
  Speaker 2: scary one for me. But in general, that's great. I'm
• 17:13
  Speaker 2: just you've depressed me. So it's not everybody else about
• 17:17
  Speaker 2: to die next week. It's I'm about to die next week.
• 17:19
  Speaker 2: Thank you, Jim. So that's why I consider you such
• 17:23
  Speaker 2: a good friend. Okay, Jim, I was just reading about
• 17:26
  Speaker 2: a drug. That's not going to be this topic, but
• 17:29
  Speaker 2: a drug that has just been approved by the FDA
• 17:32
  Speaker 2: for pancreatic cancer, which they're saying is an incredible feat
• 17:39
  Speaker 2: because it's a pancreatic. Pancreatic cancer up here before couldn't
• 17:44
  Speaker 2: be touched for the most part. And then there's a
• 17:45
  Speaker 2: new one, a new melanoma vaccine. Let's start with that one,
• 17:50
  Speaker 2: a melanoma vaccine. That seems to me like a pretty
• 17:53
  Speaker 2: big deal.
• 17:55
  Speaker 4: Yeah, it's a big deal. I mean, melanoma is a
• 17:57
  Speaker 4: difficult cancer to treat. And so what this isn't, you know,
• 18:02
  Speaker 4: we think of vaccines as you give them to a
• 18:04
  Speaker 4: healthy person and it stops the disease from happening. So
• 18:06
  Speaker 4: it's a little different than that. It is somebody with
• 18:10
  Speaker 4: melanoma that you're giving this vaccine. And melanoma is a
• 18:13
  Speaker 4: really good target for this because it has so many mutations.
• 18:16
  Speaker 4: That's what's crazy about it. It creates lots of mutations
• 18:19
  Speaker 4: within the cancer. But all those mutations are targets for antibodies, right,
• 18:24
  Speaker 4: or antigens. They're antigens targeted for antibodies. So what happens
• 18:28
  Speaker 4: is this vaccine is personalized, right? They can take the tumor.
• 18:32
  Speaker 4: They personalize this mRNA delivered vaccine that you then inject
• 18:37
  Speaker 4: back in the body. And it teaches the T cells,
• 18:40
  Speaker 4: the killer T cells, how to attack the cancer. But
• 18:45
  Speaker 4: we need Keytruda because cancer cells, especially melanoma cancer cells,
• 18:50
  Speaker 4: have this thing, PD-1, that will block. It's like a
• 18:55
  Speaker 4: little mask and it says, hey, don't attack me. I'm
• 18:58
  Speaker 4: not a bad guy. Right. And so Keytruda turned that off.
• 19:02
  Speaker 4: But then the mRNA vaccine turns on the T cells
• 19:06
  Speaker 4: to be able to recognize and attack these cancers. And
• 19:09
  Speaker 4: what they're finding is that it works really well. And,
• 19:13
  Speaker 4: you know, they had a stage two trial, which is
• 19:15
  Speaker 4: more about dosing. And that was about four or five
• 19:17
  Speaker 4: years ago. And they're finding that these these results persist.
• 19:20
  Speaker 4: So five years later, people are still surviving their melanoma
• 19:25
  Speaker 4: because it seems to It seems to teach the immune
• 19:28
  Speaker 4: system how to attack this cancer.
• 19:29
  Speaker 2: All right, a couple of questions. First of all, how
• 19:31
  Speaker 2: many cancers are there that medical science recognizes?
• 19:36
  Speaker 4: I have no idea. A lot.
• 19:40
  Speaker 2: Like hundreds, dozens?
• 19:42
  Speaker 4: Yeah, probably hundreds.
• 19:45
  Speaker 2: Wow. And each one has to be dealt with separately?
• 19:48
  Speaker 1: Yes.
• 19:50
  Speaker 2: At this point, no magic bullet that it deals with
• 19:54
  Speaker 2: most or all of cancer, right?
• 19:57
  Speaker 4: Yeah, there's no magic bullet for all of it, but
• 19:59
  Speaker 4: some overlap, right? So there's some treatments that work for
• 20:02
  Speaker 4: one that also work for another cancer.
• 20:04
  Speaker 2: All right, so let's talk about testing for a moment.
• 20:07
  Speaker 2: And that is, I had read that Some tests are
• 20:11
  Speaker 2: so effective, so overwhelmingly effective in the middle of the
• 20:16
  Speaker 2: test that they just stop the test and don't do
• 20:19
  Speaker 2: a control group anymore. Everybody just gets the drug. Am
• 20:21
  Speaker 2: I right on that?
• 20:24
  Speaker 4: Yes, you're talking not about testing, but about the research
• 20:26
  Speaker 4: side where they're researching a new drug and halfway through
• 20:30
  Speaker 4: they say, well, it's unethical to continue because we're letting
• 20:33
  Speaker 4: the control arm die and we're seeing that the people
• 20:37
  Speaker 4: we're treating are all surviving. Yeah, that happens from time
• 20:40
  Speaker 4: to time.
• 20:41
  Speaker 2: And so I'm assuming then that that is considered the
• 20:43
  Speaker 2: magic drug for that particular illness. At least I would
• 20:46
  Speaker 2: think so.
• 20:47
  Speaker 4: It becomes probably the new drug if that's what if
• 20:50
  Speaker 4: it's that effective. And, you know, that's kind of the
• 20:52
  Speaker 4: home run. Right. For the development team is if they
• 20:54
  Speaker 4: can have that news article go out that this was
• 20:58
  Speaker 4: so effective, we stopped the trial early.
• 20:59
  Speaker 1: Right.
• 21:00
  Speaker 3: Yeah.
• 21:01
  Speaker 4: I even though.
• 21:02
  Speaker 2: Yeah, absolutely. Even though we haven't talked about this and
• 21:05
  Speaker 2: it wasn't on our list. I don't know if you're
• 21:08
  Speaker 2: familiar with the new drug dealing with pancreatic cancer, which
• 21:12
  Speaker 2: I'm also understanding is incredible that an oncology group, the
• 21:17
  Speaker 2: medical group, gave in the audience a standing ovation for
• 21:21
  Speaker 2: the announcement of this drug. Are you familiar with it?
• 21:26
  Speaker 4: No, I'm not really familiar with the specific drug, but
• 21:28
  Speaker 4: I can tell you that, yes, I mean, there's two
• 21:30
  Speaker 4: types of pancreatic cancer, and the more common form is
• 21:34
  Speaker 4: one that we don't measure survival in the five-year survival
• 21:39
  Speaker 4: rate anymore because it's just so devastating that most people
• 21:42
  Speaker 4: don't live that long. So we measure the survival rate
• 21:45
  Speaker 4: in the one year, like the percentage of people alive
• 21:47
  Speaker 4: at one year, and it's low. It's very low.
• 21:51
  Speaker 2: And let me ask at this point, when we talk
• 21:54
  Speaker 2: about research– Are the researchers out there dealing with specific
• 21:58
  Speaker 2: kinds of cancer and who gets all of the money?
• 22:02
  Speaker 2: Is it the people that are just better at fundraising
• 22:05
  Speaker 2: or the prevalence of the disease?
• 22:09
  Speaker 4: Oh, wow. Yeah, that's a complicated question because getting research
• 22:14
  Speaker 4: dollars isn't definitely an art. And there's people who are
• 22:17
  Speaker 4: good at it and they write the grant applications in
• 22:21
  Speaker 4: a way that gets the attention and gets the funding.
• 22:25
  Speaker 4: And then, you know, there's also areas in science that
• 22:29
  Speaker 4: are being supported more right now than others. And so
• 22:32
  Speaker 4: people in those areas are more likely to get the funding.
• 22:35
  Speaker 4: That's a whole kind of... It's political, and there's a
• 22:42
  Speaker 4: whole socioeconomic system that goes on there. I've never written
• 22:46
  Speaker 4: a grant, so I'm not familiar with it, but I
• 22:48
  Speaker 4: do know people that have written grants and tell me, yeah,
• 22:52
  Speaker 4: you definitely learn what they're looking for, how to write it,
• 22:56
  Speaker 4: and everything. and how to get your funding, but also
• 22:59
  Speaker 4: how to create a research project that is meaningful, that
• 23:02
  Speaker 4: has meaningful endpoints and that you can do in the
• 23:05
  Speaker 4: timeframe and the money allowed. That's the other thing is
• 23:08
  Speaker 4: you can create the most beautiful research project, but if
• 23:11
  Speaker 4: you don't have the time or money to be able
• 23:13
  Speaker 4: to do it, you're just not going to get it done.
• 23:15
  Speaker 1: Right.
• 23:16
  Speaker 2: Uh, Jim, uh, as always, thank you much. Uh, and
• 23:19
  Speaker 2: thank you for that gift certificate, by the way. I
• 23:20
  Speaker 2: don't know if you sent that. You got the picture
• 23:22
  Speaker 2: of me, uh, having dinner last night on you. Uh,
• 23:25
  Speaker 2: that was, yes.
• 23:26
  Speaker 4: Yes.
• 23:27
  Speaker 2: All right.
• 23:28
  Speaker 3: That's it.
• 23:30
  Speaker 4: One of our favorite places. Yeah.
• 23:31
  Speaker 3: All right.
• 23:32
  Speaker 4: I'm glad you enjoyed it.
• 23:33
  Speaker 3: I did.
• 23:33
  Speaker 2: And I'm glad we're telling everybody how great a dinner
• 23:37
  Speaker 2: I had and they didn't.
• 23:39
  Speaker 3: But that's what this show is. Why don't you tell
• 23:40
  Speaker 3: them the restaurant so we can all learn?
• 23:44
  Speaker 2: Okay. It's actually in San Juan Capistrano. It's called Tannins. Oh.
• 23:49
  Speaker 2: It's very nice. Very, very nice. Okay. We're done. Jim,
• 23:53
  Speaker 2: thank you. We'll talk again. All right.
• 23:56
  Speaker 4: Bye. Bye.
• 23:57
  Speaker 2: Yeah, that's applied for the restaurant. I should take you
• 23:59
  Speaker 2: there when you're down in Orange County next time, Neil.
• 24:03
  Speaker 1: Sure.
• 24:04
  Speaker 3: Next time I have four hours to get to your place?
• 24:06
  Speaker 2: Yeah, pretty much.
• 24:07
  Speaker 3: Do I have to wear a costume?
• 24:09
  Speaker 2: Yeah, absolutely.
• 24:10
  Speaker 3: All of that.
• 24:11
  Speaker 2: Well, we are completely done for Wednesday. We're back again tomorrow.
• 24:15
  Speaker 2: Strange as it may seem, Neil comes in with me
• 24:20
  Speaker 2: at 6 o'clock to 9 o'clock. It starts at five
• 24:23
  Speaker 2: o'clock with Will and Amy and then Kono. Oh, come on, Will.
• 24:28
  Speaker 2: You're giving me the big two thumbs up. And then
• 24:31
  Speaker 2: Ann and Kono in the background who should be in
• 24:36
  Speaker 2: the background. That's the entire.
• 24:38
  Speaker 1: You've been listening to The Bill Handel Show. Catch my
• 24:40
  Speaker 1: show Monday through Friday, 6 a.m. to 9 a.m. and
• 24:44
  Speaker 1: anytime on demand on the iHeartRadio app.